Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Livanova Plc OR Sh (LIVN)

Livanova Plc OR Sh (LIVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,894,425
  • Shares Outstanding, K 54,152
  • Annual Sales, $ 1,154 M
  • Annual Income, $ 17,550 K
  • 60-Month Beta 0.99
  • Price/Sales 2.52
  • Price/Cash Flow 12.68
  • Price/Book 2.42
Trade LIVN with:

Options Overview Details

View History
  • Implied Volatility 55.46% ( -1.33%)
  • Historical Volatility 30.59%
  • IV Percentile 89%
  • IV Rank 63.29%
  • IV High 72.25% on 02/20/24
  • IV Low 26.53% on 09/13/23
  • Put/Call Vol Ratio 5.85
  • Today's Volume 788
  • Volume Avg (30-Day) 125
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 3,561
  • Open Int (30-Day) 8,496

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.66
  • Number of Estimates 3
  • High Estimate 0.67
  • Low Estimate 0.65
  • Prior Year 0.78
  • Growth Rate Est. (year over year) -15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.85 +7.54%
on 07/10/24
55.58 -3.54%
on 07/23/24
-0.86 (-1.58%)
since 06/26/24
3-Month
49.82 +7.61%
on 06/06/24
64.47 -16.85%
on 05/06/24
-1.92 (-3.46%)
since 04/26/24
52-Week
42.75 +25.40%
on 12/05/23
64.47 -16.85%
on 05/06/24
-5.26 (-8.93%)
since 07/26/23

Most Recent Stories

More News
LivaNova: Q1 Earnings Snapshot

LivaNova: Q1 Earnings Snapshot

LIVN : 53.61 (+0.30%)
LivaNova: Q4 Earnings Snapshot

LivaNova: Q4 Earnings Snapshot

LIVN : 53.61 (+0.30%)
LivaNova: Q3 Earnings Snapshot

LivaNova: Q3 Earnings Snapshot

LIVN : 53.61 (+0.30%)
LivaNova: Q2 Earnings Snapshot

LivaNova: Q2 Earnings Snapshot

LIVN : 53.61 (+0.30%)
LivaNova: Q1 Earnings Snapshot

LivaNova: Q1 Earnings Snapshot

LIVN : 53.61 (+0.30%)
LivaNova Reports First-Quarter 2023 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2023 and raised full-year 2023 guidance.

LIVN : 53.61 (+0.30%)
LivaNova Board of Directors Announce Leadership Changes

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald has resigned as Chief Executive Officer. Effective immediately, Chair of the...

LIVN : 53.61 (+0.30%)
BDX : 237.30 (+1.94%)
COO : 93.21 (+0.57%)
LivaNova to Announce First-Quarter 2023 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2023 results on Wednesday, May 3, 2023 at 1 p.m. London...

LIVN : 53.61 (+0.30%)
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenzâ„¢ Heart-Lung...

LIVN : 53.61 (+0.30%)
LivaNova to Present at the Barclays Global Healthcare Conference

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present in a fireside chat at the Barclays Global...

LIVN : 53.61 (+0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London,...

See More

Key Turning Points

3rd Resistance Point 55.02
2nd Resistance Point 54.50
1st Resistance Point 54.06
Last Price 53.61
1st Support Level 53.10
2nd Support Level 52.58
3rd Support Level 52.14

See More

52-Week High 64.47
Fibonacci 61.8% 56.18
Fibonacci 50% 53.61
Last Price 53.61
Fibonacci 38.2% 51.05
52-Week Low 42.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar